Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 3151 AL 3165

Chromium picolinate attenuates cognitive deficit in ICV-STZ rat paradigm of sporadic Alzheimer's-like dementia via targeting neuroinflammatory and IRS-1/PI3K/AKT/GSK-3β pathway

Akhtar A, Dhaliwal J, Saroj P, Uniyal A, Bishnoi M, Sah SP.

Inflammopharmacology. 2020 Apr;28(2):385-400. doi: 10.1007/s10787-019-00681-7. Epub 2020 Jan 3.

Efficacy and Safety of Psychostimulants for Alzheimer's Disease: A Systematic Review and Meta-Analysis

Kishi T, Sakuma K, Iwata N.

Pharmacopsychiatry. 2020 Apr;53(3):109-114. doi: 10.1055/a-1076-8228. Epub 2020 Jan 30.

Antiviral therapy: Valacyclovir Treatment of Alzheimer's Disease (VALAD) Trial: protocol for a randomised, double-blind,placebo-controlled, treatment trial

Devanand DP, Andrews H, Kreisl WC, Razlighi Q, Gershon A, Stern Y, Mintz A, Wisniewski T, Acosta E, Pollina J, Katsikoumbas M, Bell KL, Pelton GH, Deliyannides D, Prasad KM, Huey ED.

BMJ Open. 2020 Feb 6;10(2):e032112. doi: 10.1136/bmjopen-2019-032112.

An evaluation of hydromethylthionine as a treatment option for Alzheimer's disease

Hashweh NN, Bartochowski Z, Khoury R, Grossberg GT.

Expert Opin Pharmacother. 2020 Apr;21(6):619-627. doi: 10.1080/14656566.2020.1719066. Epub 2020 Feb 8.

Impact of HMGB1, RAGE, and TLR4 in Alzheimer's Disease (AD): From Risk Factors to Therapeutic Targeting

Paudel YN, Angelopoulou E, Piperi C, Othman I, Aamir K, Shaikh MF.

Cells. 2020 Feb 7;9(2):383. doi: 10.3390/cells9020383.

The Interactions Between Alzheimer's Disease and Major Depression: Role of Ca(2+) Channel Blockers and Ca(2+)/cAMP Signalling

Bergantin LB.

Curr Drug Res Rev. 2020;12(2):97-102. doi: 10.2174/2589977512666200217093356.

A Systematic Review of Clinical Studies on the Effect of Psychoactive Cannabinoids in Psychiatric Conditions in Alzheimer Dementia

Paunescu H, Dima L, Ghita I, Coman L, Ifteni PI, Fulga I, Coman OA.

Am J Ther. 2020 May/Jun;27(3):e249-e269. doi: 10.1097/MJT.0000000000001120.

Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment

Lombardi G, Crescioli G, Cavedo E, Lucenteforte E, Casazza G, Bellatorre AG, Lista C, Costantino G, Frisoni G, Virgili G, Filippini G.

Cochrane Database Syst Rev. 2020 Mar 2;3(3):CD009628. doi: 10.1002/14651858.CD009628.pub2.

Oxidative Stress in the Pathogenesis of Alzheimer's Disease and Cerebrovascular Disease with Therapeutic Implications

Jurcau A, Simion A.

CNS Neurol Disord Drug Targets. 2020;19(2):94-108. doi: 10.2174/1871527319666200303121016.

Pesticides, cognitive functions and dementia: A review

Aloizou AM, Siokas V, Vogiatzi C, Peristeri E, Docea AO, Petrakis D, Provatas A, Folia V, Chalkia C, Vinceti M, Wilks M, Izotov BN, Tsatsakis A, Bogdanos DP, Dardiotis E.

Toxicol Lett. 2020 Jun 15;326:31-51. doi: 10.1016/j.toxlet.2020.03.005. Epub 2020 Mar 4.

Molecular Insight into the Therapeutic Promise of Flavonoids against Alzheimer's Disease

Uddin MS, Kabir MT, Niaz K, Jeandet P, Clément C, Mathew B, Rauf A, Rengasamy KRR, Sobarzo-Sánchez E, Ashraf GM, Aleya L.

Molecules. 2020 Mar 11;25(6):1267. doi: 10.3390/molecules25061267.

APOE genotype-dependent pharmacogenetic responses to rapamycin for preventing Alzheimer's disease

Lin AL, Parikh I, Yanckello LM, White RS, Hartz AMS, Taylor CE, McCulloch SD, Thalman SW, Xia M, McCarty K, Ubele M, Head E, Hyder F, Sanganahalli BG.

Neurobiol Dis. 2020 Jun;139:104834. doi: 10.1016/j.nbd.2020.104834. Epub 2020 Mar 12.

One-Year Evaluation of a Targeted Medication Therapy Management Intervention for Older Adults

Martinez AI, Abner EL, Jicha GA, Rigsby DN, Eckmann LC, Huffmyer MJ, Moga DC.

J Manag Care Spec Pharm. 2020 Apr;26(4):520-528. doi: 10.18553/jmcp.2020.26.4.520.

Terpenoids, Cannabimimetic Ligands, beyond the Cannabis Plant

Gonçalves ECD, Baldasso GM, Bicca MA, Paes RS, Capasso R, Dutra RC.

Molecules. 2020 Mar 29;25(7):1567. doi: 10.3390/molecules25071567.

Initiation of symptomatic medication in Alzheimer's disease clinical trials: Hypothetical versus treatment policy approach

Donohue MC, Model F, Delmar P, Volye N, Liu-Seifert H, Rafii MS, Aisen PS; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2020 May;16(5):797-803. doi: 10.1002/alz.12058. Epub 2020 Apr 8.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias